HIV Diagnostics Market to Witness Robust Growth from USD 3.25 Billion in 2023 to USD 7.2 Billion by 2034
The global sales of HIV diagnostics is estimated to be worth USD 3,497.2 million in 2024 and anticipated to reach a value of USD 7,207.7 million by 2034. Sales are projected to rise at a CAGR of 7.5% over the forecast period between 2024 and 2034. The revenue generated by HIV diagnostics in 2023 was USD 3,253.2 million. The HIV Diagnostics Market plays a pivotal role in global health by providing the tools necessary for early detection, accurate monitoring, and effective management of HIV infections. As HIV remains a persistent public health challenge worldwide, the demand for precise and accessible diagnostic tools has never been more critical. The market encompasses a wide range of technologies, including antibody tests, nucleic acid tests, and rapid diagnostic kits that help identify HIV infections at various stages. Over the past few decades, significant advancements in diagnostic technology have transformed the landscape of HIV testing. Modern diagnostics not o...